Dr. Gill trained in Geriatric Medicine and cares for older patients with geriatric syndromes in both the inpatient and outpatient setting at St. Mary’s of the Lake Hospital and Kingston General Hospital. He did his MSc in Clinical Epidemiology at the University of Toronto, with a focus on health services research using administrative health care databases. His research interests relate to postmarketing pharmacosurveillance of medications used by older adults (e.g. medications used to manage symptoms of dementia) and health services research as it relates more broadly to the care of older individuals. He has salary support from a Canadian Institutes of Health Research (CIHR) New Investigator award.
- Stephenson A, Seitz D, Bell CM, Gruneir A, Gershon AS, Austin PC, Fu L, Anderson GM, Rochon PA, Gill SS. Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. Archives of Internal Medicine. 2011;171(10):914-920.
- Gill SS, Anderson GM, Fischer HD, Bell CM, Li P, Normand SLT, Rochon PA. Syncope and its consequences in patients with dementia receiving cholinesterase inhibitors: a population-based cohort study. Archives of Internal Medicine. 2009;169(9):867-873.
- Gill SS, Bronskill SE, Normand SLT, Anderson GM, Sykora K, Lam K, Bell CM, Lee PE, Fischer HD, Herrmann N, Gurwitz JH, Rochon PA. Antipsychotic drug use and mortality among older adults with dementia. Annals of Internal Medicine. 2007;146(11):775-786.
- Gill SS, Rochon PA, Herrmann N, Lee PE, Sykora K, Gunraj N, Normand S-LT, Gurwitz JH, Marras C, Wodchis WP, Mamdani M. Atypical antipsychotic drugs and risk of ischemic stroke: population based retrospective cohort study. British Medical Journal (BMJ). 2005;330(7489):445-448.
- Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, Shulman KI, Lee PE, Rochon PA. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Archives of Internal Medicine. 2005;165(7):808-813.